Breast cancer patients who message their doctors about certain topics are more likely to discontinue hormone therapy than others, enabling doctors to better predict which patients are at risk of stopping their treatment early.
News: Cancer Health Outcomes and Control Research Program
A recent study shows that a cell receptor, SSTR2, is a candidate biomarker for poor prognosis and a potential therapeutic target for small cell lung cancer.
A recent study suggests that a transporter protein called xCT may be potential therapeutic target in lung cancer.
Vanderbilt University Medical Center has been awarded a two-year, $250,000 grant by The Robert Wood Johnson Foundation to develop new ways to measure trust in African-American men as it relates to health care.
Consuelo Wilkins, MD, MSCI, has been appointed director of a new Engagement Core to support the design, implementation and governance of the national All of Us Research Program, an ambitious effort led by the National Institutes of Health (NIH) to accelerate the prevention and treatment of illness through precision medicine.
Derek M. Griffith has been selected for the American Association of Health Behavior Fellows Class of 2017. Griffith, who is an associate professor of Medicine, Health, and Society and founder and director of the Center for Research on Men’s Health at Vanderbilt, is being recognized for his significant contributions in the field of health behavior research.
Rising obesity rates in several Southern states are leading to a rapid increase in new cases of diabetes among both black and white adults. A new study helmed by investigators at the University of Texas Health Science Center and Vanderbilt University Medical Center (VUMC) found the risk of diabetes is double for black patients.
Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.
A simple blood test is allowing Vanderbilt University Medical Center (VUMC) researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.
The Vanderbilt-Ingram Cancer Center Neurofibromatosis (NF) Clinic has joined the Children’s Tumor Foundation NF Clinic Network. The network consists of 50 clinics dedicated to improving care and advancing research for people diagnosed with NF, a group of diseases that is often inherited and cause benign tumors to grow on nerves throughout the body.